Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Technology Assessment Trial of Prostate Vaporization Techniques in a Canadian Hospital

NCT03495258 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT03495258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03495258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Technology Assessment Trial of Prostate Vaporization Techniques in a Canadian Hospital
Lead sponsor
Queen's University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
July 8, 2016
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

3 month efficacy evaluation (compared to baseline) using validated symptom assessment tools (see outcome metrics for details), complications (post-op retention, bleeding, re-admission to hospital, infection etc), direct costs excluding capital equipment purchase, operative parameters (time, bleeding etc), operator (surgeon) completed questionnaire